{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:39:19Z","timestamp":1788982759758,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["930461"],"award-info":[{"award-number":["930461"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.xphs.2024.11.025","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:40:47Z","timestamp":1733186447000},"page":"1133-1141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Assessment of immunogenicity and protective efficiency of multi-epitope antigen-loaded in mannan decorated PLGA nanoparticles against tuberculosis"],"prefix":"10.1016","volume":"114","author":[{"given":"Yousef","family":"Amini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Kabiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid Amel","family":"Jamehdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Sankian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Meshkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirwan","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman","family":"Soleimanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Farsiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bagher","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Tafaghodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2024.11.025_bib0001","series-title":"Global Tuberculosis Report 2022","first-page":"3","author":"Organization","year":"2022"},{"issue":"4","key":"10.1016\/j.xphs.2024.11.025_bib0002","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","volume":"45","author":"L\u00f6nnroth","year":"2015","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.xphs.2024.11.025_bib0003","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3201\/eid2005.131037","article-title":"Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005\u20132007","volume":"20","author":"Marks","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"24","key":"10.1016\/j.xphs.2024.11.025_bib0004","doi-asserted-by":"crossref","first-page":"10587","DOI":"10.1007\/s00253-015-6962-x","article-title":"A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection","volume":"99","author":"Yuan","year":"2015","journal-title":"Appl Microbiol Biotechnol"},{"issue":"8986","key":"10.1016\/j.xphs.2024.11.025_bib0005","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.xphs.2024.11.025_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122560","article-title":"Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-\u03b3+ IL-2+ CD4+ and IFN-\u03b3+ CD8+ T cells","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"issue":"32","key":"10.1016\/j.xphs.2024.11.025_bib0007","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1016\/j.vaccine.2010.05.063","article-title":"Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein","volume":"28","author":"Shi","year":"2010","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.xphs.2024.11.025_bib0008","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.vaccine.2011.06.029","article-title":"Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice","volume":"30","author":"Yuan","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.xphs.2024.11.025_bib0009","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s12257-016-0326-y","article-title":"TB trifusion antigen adsorbed on calcium phosphate nanoparticles stimulates strong cellular immunity in mice","volume":"21","author":"Amini","year":"2016","journal-title":"Biotechnol Bioprocess Eng"},{"issue":"53","key":"10.1016\/j.xphs.2024.11.025_bib0010","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001094","article-title":"A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis","volume":"2","author":"Bertholet","year":"2010","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.xphs.2024.11.025_bib0011","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1073\/pnas.1314973111","article-title":"Tuberculosis vaccine with high predicted population coverage and compatibility with modern diagnostics","volume":"111","author":"Knudsen","year":"2014","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"10.1016\/j.xphs.2024.11.025_bib0012","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1080\/21645515.2016.1197454","article-title":"A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosis","volume":"12","author":"Griffiths","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.xphs.2024.11.025_bib0013","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/21691401.2016.1146735","article-title":"Development of an effective delivery system for intranasal immunization against Mycobacterium tuberculosis ESAT-6 antigen","volume":"45","author":"Amini","year":"2017","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"48","key":"10.1016\/j.xphs.2024.11.025_bib0014","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1016\/j.vaccine.2008.09.025","article-title":"Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c)","volume":"26","author":"Romano","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.xphs.2024.11.025_bib0015","first-page":"1","article-title":"Aluminum hydroxide nanoparticles show strong activity to stimulate Th-1 immune response against tuberculosis","author":"Amini","year":"2016","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1016\/j.xphs.2024.11.025_bib0016","article-title":"Advances in protein subunit vaccines against tuberculosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2024.11.025_bib0017","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41541-023-00666-2","article-title":"A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG","volume":"8","author":"Dijkman","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.xphs.2024.11.025_bib0018","first-page":"116","article-title":"The dry powder formulation of mixed cross-linked dextran microspheres and tetanus toxoid-loaded trimethyl chitosan nanospheres as a potent adjuvant for nasal delivery system","volume":"24","author":"Kabiri","year":"2021","journal-title":"Iran J Basic Med Sci"},{"issue":"5","key":"10.1016\/j.xphs.2024.11.025_bib0019","doi-asserted-by":"crossref","first-page":"e63344","DOI":"10.1371\/journal.pone.0063344","article-title":"Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice","volume":"8","author":"Todoroff","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.xphs.2024.11.025_bib0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.exppara.2011.07.007","article-title":"Alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis","volume":"129","author":"Tafaghodi","year":"2011","journal-title":"Exp Parasitol"},{"issue":"8","key":"10.1016\/j.xphs.2024.11.025_bib0021","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s12272-013-0043-4","article-title":"Dry-powder form of chitosan nanospheres containing influenza virus and adjuvants for nasal immunization","volume":"36","author":"Dehghan","year":"2013","journal-title":"Arch Pharm Res"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2024.11.025_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2014.08.032","article-title":"Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants","volume":"475","author":"Dehghan","year":"2014","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2024.11.025_bib0023","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/17425247.2023.2223941","article-title":"Biomedical applications of PLGA nanoparticles in nanomedicine: advances in drug delivery systems and cancer therapy","volume":"20","author":"Narmani","year":"2023","journal-title":"Expert Opin Drug Deliv"},{"issue":"11","key":"10.1016\/j.xphs.2024.11.025_bib0024","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s12272-010-1119-z","article-title":"Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen","volume":"33","author":"Lee","year":"2010","journal-title":"Arch Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2024.11.025_bib0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/10837450903479962","article-title":"Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit","volume":"16","author":"Mohaghegh","year":"2011","journal-title":"Pharm Dev Technol"},{"issue":"3","key":"10.1016\/j.xphs.2024.11.025_bib0026","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2217\/nnm.14.116","article-title":"Surface functionalization of polymeric nanospheres modulates macrophage activation: relevance in Leishmaniasis therapy","volume":"10","author":"Barros","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.xphs.2024.11.025_bib0027","doi-asserted-by":"crossref","DOI":"10.1039\/D4NR00680A","article-title":"Advances in engineered nanosystems: immunomodulatory interactions for therapeutic applications","author":"Khatua","year":"2024","journal-title":"Nanoscale"},{"issue":"4","key":"10.1016\/j.xphs.2024.11.025_bib0028","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/1061186X.2010.499463","article-title":"Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles","volume":"19","author":"Ghotbi","year":"2011","journal-title":"J Drug Target"},{"issue":"3","key":"10.1016\/j.xphs.2024.11.025_bib0029","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2217\/nnm.14.116","article-title":"Surface functionalization of polymeric nanospheres modulates macrophage activation: relevance in Leishmaniasis therapy","volume":"10","author":"Barros","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.xphs.2024.11.025_bib0030","series-title":"Surface-Modified Drug Delivery Systems for Tuberculosis Intervention. Tubercular Drug Delivery Systems: Advances in Treatment of Infectious Diseases","first-page":"261","author":"Ayodele","year":"2023"},{"issue":"12","key":"10.1016\/j.xphs.2024.11.025_bib0031","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1021\/bc8002524","article-title":"Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes","volume":"19","author":"Espuelas","year":"2008","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.xphs.2024.11.025_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e26193","article-title":"Tuberculosis vaccine developments and efficient delivery systems: a comprehensive appraisal","author":"Hoseinpour","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.xphs.2024.11.025_bib0033","first-page":"125","article-title":"Heterologous expression, purification, and characterization of the HspX, Ppe44, and EsxV proteins of Mycobacterium tuberculosis","volume":"6","author":"Amini","year":"2018","journal-title":"Rep Biochem Mol Biol"},{"issue":"2","key":"10.1016\/j.xphs.2024.11.025_bib0034","first-page":"89","article-title":"Construction of a novel DNA vaccine candidate encoding an HspX-PPE44-EsxV fusion antigen of Mycobacterium tuberculosis","volume":"4","author":"Moradi","year":"2016","journal-title":"Rep Biochem Mol Biol"},{"issue":"1","key":"10.1016\/j.xphs.2024.11.025_bib0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-5173(99)00107-6","article-title":"Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification","volume":"184","author":"Lamprecht","year":"1999","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2024.11.025_bib0036","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/jlcr.1600","article-title":"Synthesis and biodistribution studies of iodine-131 d-amino acid YYK peptide as a potential therapeutic agent for labeling an anti-CD20 antibody","volume":"52","author":"Sadri","year":"2009","journal-title":"J Labelled Comp Radiopharm"},{"issue":"6","key":"10.1016\/j.xphs.2024.11.025_bib0037","first-page":"613","article-title":"Different methods to determine the encapsulation efficiency of protein in PLGA nanoparticles","volume":"28","author":"Amini","year":"2017","journal-title":"Biomed Mater Eng"},{"key":"10.1016\/j.xphs.2024.11.025_bib0038","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejpb.2018.11.003","article-title":"Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles","volume":"133","author":"Kabiri","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"issue":"1\u20133","key":"10.1016\/j.xphs.2024.11.025_bib0039","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0168-3659(02)00275-4","article-title":"Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres","volume":"85","author":"Diwan","year":"2002","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2024.11.025_bib0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ab.2004.12.001","article-title":"Carbohydrate analysis by a phenol\u2013sulfuric acid method in microplate format","volume":"339","author":"Masuko","year":"2005","journal-title":"Anal Biochem"},{"issue":"7","key":"10.1016\/j.xphs.2024.11.025_bib0041","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1039\/C6MB00174B","article-title":"Fc-based delivery system enhances immunogenicity of a tuberculosis subunit vaccine candidate consisting of the ESAT-6: CFP-10 complex","volume":"12","author":"Farsiani","year":"2016","journal-title":"Mol Biosyst"},{"issue":"1","key":"10.1016\/j.xphs.2024.11.025_bib0042","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ni.3048","article-title":"The balance between protective and pathogenic immune responses in the TB-infected lung","volume":"16","author":"Orme","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.xphs.2024.11.025_bib0043","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/854507","article-title":"Th1 and Th17 cells in tuberculosis: protection, pathology, and biomarkers","volume":"2015","author":"Lyadova","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"1","key":"10.1016\/j.xphs.2024.11.025_bib0044","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/vaccines12010038","article-title":"Enhancing TB vaccine efficacy: current progress on vaccines, adjuvants and immunization strategies","volume":"12","author":"Wang","year":"2023","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.xphs.2024.11.025_bib0045","first-page":"125","article-title":"Heterologous expression, purification, and characterization of the HspX, Ppe44, and EsxV proteins of Mycobacterium tuberculosis","volume":"6","author":"Amini","year":"2018","journal-title":"Rep Biochem Mol Biol"},{"issue":"2","key":"10.1016\/j.xphs.2024.11.025_bib0046","first-page":"156","article-title":"Increasing cellular immune response in liposomal formulations of DOTAP encapsulated by fusion protein Hspx, PPE44, and Esxv, as a potential tuberculosis vaccine candidate","volume":"7","author":"Mansury","year":"2019","journal-title":"Rep Biochem Mol Biol"},{"issue":"1","key":"10.1016\/j.xphs.2024.11.025_bib0047","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/21691401.2018.1557674","article-title":"Enhancement of the effect of BCG vaccine against tuberculosis using DDA\/TDB liposomes containing a fusion protein of HspX, PPE44, and EsxV","volume":"47","author":"Mansury","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"7","key":"10.1016\/j.xphs.2024.11.025_bib0048","first-page":"909","article-title":"A new DNA vaccine expressing HspX-PPE44-EsxV fusion antigens of Mycobacterium tuberculosis induced strong immune responses","volume":"23","author":"Moradi","year":"2020","journal-title":"Iran J Basic Med Sci"},{"issue":"4","key":"10.1016\/j.xphs.2024.11.025_bib0049","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.intimp.2010.12.005","article-title":"CpG oligodeoxynucleotide-adjuvanted fusion peptide derived from HBcAg epitope and HIV-Tat may elicit favorable immune response in PBMCs from patients with chronic HBV infection in the immunotolerant phase","volume":"11","author":"Wang","year":"2011","journal-title":"Int Immunopharmacol"},{"issue":"48","key":"10.1016\/j.xphs.2024.11.025_bib0050","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1016\/j.vaccine.2014.06.065","article-title":"Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer","volume":"32","author":"Scheiermann","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.xphs.2024.11.025_bib0051","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1128\/IAI.68.5.2948-2953.2000","article-title":"CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis","volume":"68","author":"Freidag","year":"2000","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.xphs.2024.11.025_bib0052","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1574-695X.2010.00660.x","article-title":"The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10: ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants","volume":"59","author":"Chen","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.xphs.2024.11.025_bib0053","series-title":"Immunogenicity of Therapeutic Fusion Proteins: Contributory Factors and Clinical Experience","author":"Jawa","year":"2013"},{"issue":"4","key":"10.1016\/j.xphs.2024.11.025_bib0054","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3390\/vaccines8040652","article-title":"Safety and immunogenicity of the GamTBvac, the recombinant subunit tuberculosis vaccine candidate: a phase II, multi-center, double-blind, randomized, placebo-controlled study","volume":"8","author":"Tkachuk","year":"2020","journal-title":"Vaccines"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2024.11.025_bib0055","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ijpharm.2018.07.069","article-title":"The novel immunogenic chimeric peptide vaccine to elicit potent cellular and mucosal immune responses against HTLV-1","volume":"549","author":"Kabiri","year":"2018","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2024.11.025_bib0056","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/10611860801900462","article-title":"PLGA microspheres for the delivery of a novel subunit TB vaccine","volume":"16","author":"Kirby","year":"2008","journal-title":"J Drug Target"},{"key":"10.1016\/j.xphs.2024.11.025_bib0057","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.2147\/IJN.S172391","article-title":"Single-dose Ag85B-ESAT6\u2013loaded poly (lactic-co-glycolic acid) nanoparticles confer protective immunity against tuberculosis","author":"Malik","year":"2019","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2024.11.025_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105335","article-title":"A new poly (I: C)-decorated PLGA-PEG nanoparticle promotes Mycobacterium tuberculosis fusion protein to induce comprehensive immune responses in mice intranasally","volume":"162","author":"Du","year":"2022","journal-title":"Microb Pathog"},{"issue":"8","key":"10.1016\/j.xphs.2024.11.025_bib0059","first-page":"893","article-title":"Enhancing immunogenicity of novel multistage subunit vaccine of Mycobacterium tuberculosis using PLGA: DDA hybrid nanoparticles and MPLA: subcutaneous administration","volume":"22","author":"Khademi","year":"2019","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.xphs.2024.11.025_bib0060","first-page":"1","article-title":"Immunological assessment of chitosan or trimethyl chitosan-coated PLGA nanospheres containing fusion antigen as the novel vaccine candidates against tuberculosis","volume":"23","author":"Zare","year":"2022","journal-title":"AAPS Pharmscitech"},{"key":"10.1016\/j.xphs.2024.11.025_bib0061","article-title":"Importance of adjuvant selection in tuberculosis vaccine development: exploring basic mechanisms and clinical implications","volume":"29","author":"Choi","year":"2023","journal-title":"Vaccine: X"},{"issue":"3","key":"10.1016\/j.xphs.2024.11.025_bib0062","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00044-023-03015-z","article-title":"Mannose: a potential saccharide candidate in disease management","volume":"32","author":"Dhanalakshmi","year":"2023","journal-title":"Med Chem Res"},{"issue":"4","key":"10.1016\/j.xphs.2024.11.025_bib0063","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.molimm.2007.07.020","article-title":"Keyhole limpet hemocyanin induces the activation and maturation of human dendritic cells through the involvement of mannose receptor","volume":"45","author":"Presicce","year":"2008","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2024.11.025_bib0064","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/acsomega.3c06389","article-title":"In vitro targeted delivery of simvastatin and niacin to macrophages using mannan-grafted magnetite nanoparticles","volume":"9","author":"Rastegari","year":"2023","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.xphs.2024.11.025_bib0065","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/1744666X.2020.1762572","article-title":"Nanoparticle-based immunotherapy: state of the art and future perspectives","volume":"16","author":"Di Gioacchino","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"24","key":"10.1016\/j.xphs.2024.11.025_bib0066","doi-asserted-by":"crossref","first-page":"10467","DOI":"10.1007\/s00253-015-6952-z","article-title":"APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice","volume":"99","author":"Soleimanpour","year":"2015","journal-title":"Appl Microbiol Biotechnol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924005446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924005446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T22:10:10Z","timestamp":1742681410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924005446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0022354924005446"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.11.025","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of immunogenicity and protective efficiency of multi-epitope antigen-loaded in mannan decorated PLGA nanoparticles against tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}